Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung Cancer
Clinical trial NCT02716311 · COMPLETED
Trial details
- NCT number
- NCT02716311
- Sponsor
- Intergroupe Francophone de Cancerologie Thoracique
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2019-02-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.